ArticleBMJ open2025
Epidemiology of developmental language disorder among children in the Arab countries: a scoping review.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Virtual Reality-Supported Speech Therapy in Children with Developmental Language Disorder: A Randomized Controlled Trial.Medical sciences (Basel, Switzerland) · 2026Trial
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDevelopmental language disorder (DLD) is a common communication disorder that impacts children's ability to learn, comprehend and use language effectively, yet it remains under-researched, particularly in the Arab countries. This scoping review aims to provide a comprehensive narrative summary on the epidemiology of DLD among children aged ≤10 years in the Arab countries.
designA scoping review. DATA SOURCES: PubMed, Scopus and Web of Science. ELIGIBILITY CRITERIA: We included studies that reported on the prevalence or risk factors of DLD in children aged ≤10 years from any Arab country. Only peer-reviewed publications were considered, and the study populations were required to consist of children without underlying medical conditions known to contribute to language or speech delay. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently performed abstract and full-text screening and extracted relevant data. The risk factors identified as linked to DLD were grouped into maternal and perinatal factors, factors related to children and family and environmental factors.
resultsFrom 4832 citations, 17 were deemed eligible and included in this review. The reviewed studies were conducted in only seven Arab countries, with the majority from Egypt (eight studies, 47.1%) and Saudi Arabia (four studies, 23.5%). The reported prevalence of DLD ranged from 3.2% in Egyptian children aged 3-6 years to 25.6% in Saudi Arabian children aged 1-5 years. Among the identified risk factors for DLD were sex, low birth weight, a history of speech and language delay in the family, parental socioeconomic status, perinatal complications, larger family size and early screen exposure.
conclusionThe reported prevalence of DLD varied across the seven Arab countries. Strategies to address the preventable underlying DLD-associated risk factors are required. There is a clear gap in evidence related to the burden of DLD among children in most of the 22 Arab countries, which warrants further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.